Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference174 articles.
1. Raynor DK, Blenkinsopp A, Knapp P, Grime J, Nicolson DJ, Pollock K, Dorer G, Gilbody S, Dickinson D, Maule AJ, Spoor P. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):1–98.
2. Yuan HT, Raynor DK, Aslani P. Comparison of international regulations for written medicine information (WMI) on prescription medicines. Ther Innov Regul Sci. 2019;53:215–26. https://doi.org/10.1177/2168479018776949.
3. European Commission. Guideline on the readability of the labelling and package leaflet of medicinal products for human use. Revision 1. 2009. https://ec.europa.eu/health//sites/health/files/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf. Accessed 30 Nov 2020
4. Raynor DK, Svarstad B, Knapp P, Aslani P, Brooke Rogers M, Koo M, Krass I, Silcock J. Consumer medication information in the United States, Europe, and Australia: A comparative evaluation. J Am Pharm Assoc. 2007;47:717–24. https://doi.org/10.1331/JAPhA.2007.06141.
5. Kumana CR, Ma JT, Kung A, Kou M, Lauder I. An assessment of drug information sheets for diabetic patients: only active involvement by patients is helpful. Diabet Res Clin Pract. 1988;5:225–31.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献